Series B funding round for Endeavor BioMedicines raising $100M in February 2022
Series B funding round for Endeavor BioMedicines raising $100M in February 2022
| Investor | Firm Type | Partner |
|---|
TriWise CapitalLEAD | Private | — |
Avidity PartnersLEAD | Venture Capital | — |
Andrew LamLEAD | Angel | Andrew Lam |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$292M
Top Valuation
-
Endeavor BioMedicines raised $100M in a Series B round.
The round was announced on 02/01/22.
The round was led by Andrew Lam, Andrew Lam, Monal Mehta.